US FDA Open To Cell Therapy ‘Assessment Aid’ That Could Speed Development Of Next-Gen Cancer Drugs

 
• By Kate Rawson
  
CAR-T cell
Reviewer consistency remains an issue for some cell and gene therapy sponsors. • Source: Shutterstock

More from Cell & Gene Therapies

More from Advanced Technologies